Somatropin is primarily indicated for what condition?

Somatropin is primarily indicated for growth hormone deficiency because it is a synthetic form of human growth hormone (GH). This condition occurs when there is insufficient production of growth hormone, leading to various developmental issues in children, such as short stature and delayed growth. In adults, growth hormone deficiency can result in metabolic changes and decreased quality of life. Somatropin assists in promoting growth and development by stimulating growth in various tissues, making it an effective treatment for both pediatric and adult patients suffering from this deficiency.

The other conditions listed are not treated by somatropin. For example, hypotension is managed with vasopressors or fluid resuscitation, obesity management typically involves lifestyle changes and weight-loss medications, and chronic pain syndrome is usually treated with pain relievers or therapeutic interventions. Thus, somatropin's specific role in addressing growth hormone deficiency clearly defines its primary indication.